Text Size

Preoperative Nasal Swabs From Pediatric Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT00646919
First received: March 26, 2008
Last updated: NA
Last verified: March 2008
History: No changes posted
  Purpose

We intend to take a nasal swab from each pediatric pre-operative patient in our out-clinic with the intention of looking for a connection between positive operative incisions and a positive nasal swab. The patients will be in the out-patient clinic for a few hours, and will be examined post-operatively after one week. Those with positive nasal swabs will be advised to apply a nasal cream (Mupirocin)in their noses for one week. Our hypothesis is that there is a correlation between positive nasal swabs and positive incision infections.


Condition Intervention
Staphylococcal Infections
 Procedure: Nose swab

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Double-Blind Prospective Study Concerning the Connection Between Positive Nasal Culture for Staphyloccoci in Pediatric Patients Undergoing Any Elective Surgery in the Out-Patient Clinic in the Hillel Yaffe Medical Center, Over a Period of One Year

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hillel Yaffe Medical Center:

Groups/Cohorts Assigned Interventions
1
All pre-operative pediatric patients in our outpatient clinic
 Procedure: Nose swab

  Eligibility

Ages Eligible for Study:   up to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All pediatric patients attending our outpatient surgery clinic

Criteria

Inclusion Criteria:

  • All pediatric patients attending outpatient surgery clinic

Exclusion Criteria:

  • All others
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00646919

Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Contact: Gershon Keren, MD     972-4-6304218     gershonk@hy.health.gov.il    
Sub-Investigator: Zvi Steiner, MD            
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00646919     History of Changes
Other Study ID Numbers: HY56/2007
Study First Received: March 26, 2008
Last Updated: March 26, 2008
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Staphylococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on May 21, 2013